Literature DB >> 32456910

Label-free discrimination of glioma brain tumors in different stages by surface enhanced Raman scattering.

Jingwen Li1, Chengde Wang2, Yue Yao1, Yali Zhu1, Changchun Yan1, Qichuan Zhuge3, Lulu Qu4, Caiqin Han5.   

Abstract

According to the WHO classification criteria, the most common intracranial tumor gliomas can be divided into four grades based on their symptoms. Among them, Grade Ⅰ and Grade II are low-grade gliomas, and Grade III and Grade IV are high-grade gliomas. Because gliomas have a high lethal rate, they have received widespread attention in the medical field. Based on these circumstances, a rapid and facile surface enhanced Raman scattering (SERS) method using silver nano particle-decorated silver nanorod (AgNPs@AgNR) as substrates were developed for the discrimination of gliomas. Compared with SERS-active silver nanoparticles and silver nanorod substrates, the prepared AgNPs@AgNR substrates showed an outstanding SERS performance with an enhancement factor up to 1.37 × 109. Combined AgNPs@AgNR substrate with principal component analysis (PCA), we achieved rapid discrimination of healthy brain tissue and gliomas at different grades. The spectra obtained from the tissue illustrate prominently spectral differences which can be applied to identify whether it came from a healthy region or from a glioma. The most prominently difference between the SERS spectrum of healthy brain tissue and that of gliomas at different grades is the reduction in quotient of two characteristic peaks at 653 and 724 cm-1. Furthermore, healthy brain tissue and Grade II gliomas as low grade gliomas as well as Grade III and Grade IV as high-grade gliomas can be clearly distinguished by three-dimensional PCA. Preliminary results indicate that the SERS spectra based on AgNPs@AgNR substrates can be applied for a rapid identification owing to its simple preparation of specimen and high-speed spectral acquirement.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AgNPs@AgNR; Gliomas; Hot spots; SERS

Mesh:

Substances:

Year:  2020        PMID: 32456910     DOI: 10.1016/j.talanta.2020.120983

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  2 in total

Review 1.  Exosome-based strategies for diagnosis and therapy of glioma cancer.

Authors:  Mohsen Karami Fath; Jalil Azami; Alireza Masoudi; Reza Mosaddeghi Heris; Elnaz Rahmani; Fatemeh Alavi; Armina Alagheband Bahrami; Zahra Payandeh; Bahman Khalesi; Masoomeh Dadkhah; Navid Pourzardosht; Vahideh Tarhriz
Journal:  Cancer Cell Int       Date:  2022-08-21       Impact factor: 6.429

2.  Oxidative Stress Activated by Sorafenib Alters the Temozolomide Sensitivity of Human Glioma Cells Through Autophagy and JAK2/STAT3-AIF Axis.

Authors:  Jianwei Wei; Zhengfeng Wang; Weiwei Wang; Xiaoge Liu; Junhu Wan; Yongjie Yuan; Xueyuan Li; Liwei Ma; Xianzhi Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.